Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges

Oral Dis. 2019 Oct;25(7):1815-1821. doi: 10.1111/odi.13160. Epub 2019 Aug 19.
No abstract available

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw / diagnosis*
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / drug therapy
  • Bone Density Conservation Agents / adverse effects*
  • Bone Density Conservation Agents / therapeutic use
  • Bone Resorption / physiopathology
  • Diphosphonates / adverse effects*
  • Diphosphonates / therapeutic use
  • Humans
  • Osteonecrosis / chemically induced
  • Osteonecrosis / diagnosis
  • Societies, Medical*

Substances

  • Bone Density Conservation Agents
  • Diphosphonates

Grants and funding